Yamaoka, Yoshio.
Yoshio Yamaoka researcher ORCID ID = 0000-0002-1222-5819
야마오카 요시오
山岡, 吉生
VIAF ID: 41061973 (Personal)
Permalink: http://viaf.org/viaf/41061973
Preferred Forms
-
200 _ | ‡a Yamaoka ‡b Yoshio
-
100 1 _ ‡a Yamaoka, Yoshio
-
100 1 _ ‡a Yamaoka, Yoshio
-
100 1 _ ‡a Yamaoka, Yoshio
-
-
-
-
-
-
100 0 _ ‡a Yoshio Yamaoka ‡c researcher ORCID ID = 0000-0002-1222-5819
-
100 1 _ ‡a 山岡, 吉生
-
100 1 _ ‡a 야마오카 요시오
4xx's: Alternate Name Forms (12)
Works
Title | Sources |
---|---|
Helicobacter pylori : molecular genetics and cellular biology |
![]() ![]() ![]() ![]() ![]() ![]() |
Helicobacter pylori research : from bench to bedside |
![]() ![]() ![]() |
Helicobacter pylori virulence genes and host genetic polymorphisms as risk factors for peptic ulcer disease |
![]() |
Hepatitis C virus-related cirrhosis is a major determinant of the expression levels of hepatic drug transporters. |
![]() |
High Fluoroquinolone Resistant Strains of Helicobacter pylori in the Golden triangle |
![]() |
How to eliminate gastric cancer-related death worldwide? |
![]() |
Identification of Helicobacter pylori infection in symptomatic patients in Surabaya, Indonesia, using five diagnostic tests. |
![]() |
Impact of Helicobacter pylori CagA diversity on gastric mucosal damage: an immunohistochemical study of East-Asian-type CagA |
![]() |
Importance of Toll-like Receptors in Pro-inflammatory and Anti-inflammatory Responses by Helicobacter pylori Infection |
![]() |
In silico evolutionary analysis of Helicobacter pylori outer membrane phospholipase A (OMPLA) |
![]() |
Initial Trials With Susceptibility-Based and Empiric Anti- Therapies in Mongolia |
![]() |
The Interleukin-1 RN Polymorphism and Helicobacter pylori Infection in the Development of Duodenal Ulcer |
![]() |
Interleukin-6 genetic polymorphisms are not related to Helicobacter pylori-associated gastroduodenal diseases |
![]() |
Letter: are microbes other than Helicobacter pylori associated with gastric cancer? Authors' reply |
![]() |
Levels of interleukin-18 are markedly increased in Helicobacter pylori-infected gastric mucosa among patients with specific IL18 genotypes |
![]() |
Living related donor liver transplantation, 1994: |
![]() ![]() ![]() ![]() |
Marked differences in the frequency of microsatellite instability in gastric cancer from different countries |
![]() |
Microbiota : current research and emerging trends |
![]() ![]() |
Multiple malignant changes and recurrent infections in the skin associated with long-term exposure to ultraviolet light and topical psoralen plus ultraviolet A therapy. |
![]() |
Novel CagA ELISA exhibits enhanced sensitivity of Helicobacter pylori CagA antibody |
![]() |
NSAID gastric ulceration: predictive value of gastric pH, mucosal density of polymorphonuclear leukocytes, or levels of IL-8 or nitrite. |
![]() |
The peopling of the Pacific from a bacterial perspective |
![]() |
The prevalence of Helicobacter pylori infection and other risk factors among Mongolian dyspeptic patients who have a high incidence and mortality rate of gastric cancer. |
![]() |
Prevalence of two homologous genes encoding glycosyltransferases of Helicobacter pylori in the United States and Japan |
![]() |
Proteomic and functional characterization of the outer membrane vesicles from the gastric pathogen Helicobacter pylori |
![]() |
The relationship between Helicobacter pylori infection and Alzheimer's disease in Japan. |
![]() |
Relationship between vacA Types and Development of Gastroduodenal Diseases |
![]() |
Reply to “dupA1 Is Associated with Duodenal Ulcer and High Interleukin-8 Secretion from the Gastric Mucosa”. |
![]() |
Reply to Pachathundikandi and Backert. |
![]() |
Risk Factors and Prevalence of Helicobacter pylori in Five Largest Islands of Indonesia: A Preliminary Study. |
![]() |
Role of Helicobacter pylori cagA EPIYA motif and vacA genotypes for the development of gastrointestinal diseases in Southeast Asian countries: a meta-analysis |
![]() |
[Role of Helicobacter pylori virulence factors on induction of cytokines from gastric epithelial cells] |
![]() |
Role of preferential cyclooxygenase-2 inhibition by meloxicam in ischemia/reperfusion injury of the rat liver |
![]() |
Role of Vonoprazan in Eradication Therapy in Japan |
![]() |
Roles of virD4 and cagG genes in the cag pathogenicity island of Helicobacter pylori using a Mongolian gerbil model |
![]() |
Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus |
![]() |
Search for novel candidate mutations for metronidazole resistance in Helicobacter pylori using next-generation sequencing. |
![]() |
Serum Helicobacter pylori CagA antibody titer as a useful marker for advanced inflammation in the stomach in Japan. |
![]() |
Survival of Helicobacter pylori in gastric acidic territory. |
![]() |
Systematic analysis of phosphotyrosine antibodies recognizing single phosphorylated EPIYA-motifs in CagA of East Asian-type Helicobacter pylori strains |
![]() |
Systematic review and meta-analysis: the relationship between the Helicobacter pylori dupA gene and clinical outcomes. |
![]() |
Therapeutic effect of lyophilized, Kefir-fermented milk on constipation among persons with mental and physical disabilities. |
![]() |
Tissue engineering for therapeutic use 1 : proceedings of the First International Symposium of Tissue Engineering for Therapeutic Use, Kyoto, Japan, 2 March 1997 |
![]() ![]() ![]() |
Traces of human migrations in Helicobacter pylori populations |
![]() |
vacA i-region subtyping |
![]() |
Variability in the interpretation of microsatellite patterns with different electrophoretic conditions. |
![]() |
Vector potential of cockroaches for Helicobacter pylori infection. |
![]() ![]() |
Virulence factor genotypes of Helicobacter pylori affect cure rates of eradication therapy |
![]() ![]() |
Western-Type Helicobacter pylori CagA are the Most Frequent Type in Mongolian Patients. |
![]() |
Whole Genome Sequencing Reveals Virulence Potentials of Helicobacter pylori Strain KE21 Isolated from a Kenyan Patient with Gastric Signet Ring Cell Carcinoma |
![]() |